Fortrea Holdings FTRE
NASDAQ FTRE
$16.79 -0.27 (-1.58%)
As of: Sep 9, 2026 · 3:59 PM EDT

Fortrea Holdings (FTRE) Long-Term Deferred Tax (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Long-Term Deferred Tax came in at $6.2 million in Q2 2026, up 10.71% on a YoY basis from $5.6 million in Q2 2025, and little changed quarter-over-quarter from $6.2 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Long-Term Deferred Tax (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has reported Long-Term Deferred Tax for 5 consecutive years, with $6.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Long-Term Deferred Tax rose 10.71% year-over-year to $6.2 million; the trailing twelve-month figure through Jun 2026 stood at $6.2 million (up 10.71% YoY), and the FY2025 full-year result was $6.2 million, up 19.23% from the prior year.
  • Long-Term Deferred Tax held at $6.2 million in Q2 2026 per FTRE's latest filing, from $6.2 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $8.3 million in Q3 2025 and bottomed at $1.2 million in Q4 2022.
  • Historically, Long-Term Deferred Tax has averaged $4.3 million across 5 years, with a median of $4.2 million in 2023.
  • The sharpest annual moves came in 2023 and 2026: Long-Term Deferred Tax soared 166.67% in 2023, then rose 10.71% in 2026.
  • Over 5 years, Long-Term Deferred Tax stood at $1.2 million in 2022, then jumped by 166.67% to $3.2 million in 2023, then soared by 62.5% to $5.2 million in 2024, then rose by 19.23% to $6.2 million in 2025, then changed by 0.0% to $6.2 million in 2026.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $6.2 million, $6.2 million, and $6.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn
6 Evotec SE 661.34 Mn 235.46 Mn -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn
10 VivoSim Labs 1.47 Mn 1.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.20 Mn
Mar 31, 2026 6.20 Mn
Dec 31, 2025 6.20 Mn
Sep 30, 2025 8.30 Mn
Jun 30, 2025 5.60 Mn
Mar 31, 2025 5.40 Mn
Dec 31, 2024 5.20 Mn
Sep 30, 2024 3.20 Mn
Jun 30, 2024 3.20 Mn
Mar 31, 2024 3.20 Mn
Dec 31, 2023 3.20 Mn
Sep 30, 2023 1.60 Mn
Jun 30, 2023 2.00 Mn
Dec 31, 2022 1.20 Mn